Although neutralization of Th2 cytokines (IL-4, IL-13) protected lean mice from AD, this treatment exacerbated disease in obese mice due to the lack of PPAR-γ expression in CD4 T cells (17). This evidence concerns the gene PPARG and Alzheimer disease.